FR3174M - Nouvel δ-3β17β-dihydroxy-7α17α-diméthyl-19-nor-androstene utilisable en thérapie. - Google Patents

Nouvel δ-3β17β-dihydroxy-7α17α-diméthyl-19-nor-androstene utilisable en thérapie.

Info

Publication number
FR3174M
FR3174M FR963624A FR963624A FR3174M FR 3174 M FR3174 M FR 3174M FR 963624 A FR963624 A FR 963624A FR 963624 A FR963624 A FR 963624A FR 3174 M FR3174 M FR 3174M
Authority
FR
France
Prior art keywords
androstene
dihydroxy
usable
therapy
dimethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR963624A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
BASF Schweiz AG
Original Assignee
Ciba Geigy AG
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1377562A external-priority patent/CH451930A/de
Priority claimed from CH93363A external-priority patent/CH435261A/de
Priority claimed from FR953819A external-priority patent/FR1403648A/fr
Application filed by Ciba Geigy AG, Ciba AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of FR3174M publication Critical patent/FR3174M/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J11/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
FR963624A 1962-11-23 1964-02-13 Nouvel δ-3β17β-dihydroxy-7α17α-diméthyl-19-nor-androstene utilisable en thérapie. Active FR3174M (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH1377562A CH451930A (de) 1962-11-23 1962-11-23 Verfahren zur Herstellung neuer Methylöstrene
CH93363A CH435261A (de) 1962-11-23 1963-01-25 Verfahren zur Herstellung neuer 19-Nor-androstene
CH792363 1963-06-26
FR953819A FR1403648A (fr) 1962-11-23 1963-11-15 Procédé pour la préparation de nouveaux 19-nor-androstènes

Publications (1)

Publication Number Publication Date
FR3174M true FR3174M (fr) 1965-03-08

Family

ID=27172539

Family Applications (1)

Application Number Title Priority Date Filing Date
FR963624A Active FR3174M (fr) 1962-11-23 1964-02-13 Nouvel δ-3β17β-dihydroxy-7α17α-diméthyl-19-nor-androstene utilisable en thérapie.

Country Status (2)

Country Link
FR (1) FR3174M (fr)
SE (1) SE319471B (fr)

Also Published As

Publication number Publication date
SE319471B (fr) 1970-01-19

Similar Documents

Publication Publication Date Title
DK105511C (da) Skøjte.
FR2973M (fr) Alpha-aminocétone.
DK112125B (da) Falstagsten.
DK105974C (da) Lastpallemagasin.
FR3377M (fr) Pommade utilisable en ophtalmologie.
FR3429M (fr) Nouvel antibiotique ussamycine utilisable en thérapeutique.
NL143659B (nl) Fluidum-en-afsluiting.
FR1898M (fr) Nouvelle substance utilisable en thérapeutique.
FR3174M (fr) Nouvel δ-3β17β-dihydroxy-7α17α-diméthyl-19-nor-androstene utilisable en thérapie.
FR3546M (fr) Azabenzocycloalcane-n-carboxamidines.
OA01221A (fr) Polythioformaldéhydes.
FR2799M (fr) Nouvelles β-phénylcyclohexylamines substituées utiles en thérapeutiques.
FR350M (fr) Nouvel antibiotique lankavamycine utilisable en thérapeutique.
FR2894M (fr) Phénylalcanolamine.
DK103099C (da) Plov.
FR3676M (fr) Nouvel antibiotique tuoromycine utilisable en thérapeutique.
FR3137M (fr) Nouvel δ<4>-7α, 17α-diméthyl-17β-hydroxy-oestrene utilisable en thérapie.
GR23055B (el) Μουσταλευρια στιγμης.
FR3800M (fr) Thérapeutique salicylique.
FI43197C (fi) Värmeväxlare, särskilt oljeförvärmare
FI40332C (fi) Tryckkänslig, häftande etylen-vinylacetatkopolymerhaltig beläggningskomposition
BE596272A (fr) Nouvelle substance utilisable en thérapeutique.
FR351M (fr) Nouvel antibiotique lankavacidine utilisable en thérapeutique.
FR352M (fr) Nouvel antibiotique ferrimycine utilisable en thérapeutique.
DK97484C (da) Bordostepresse.